Since the project’s initiation in 2019, RAPID-Health has introduced more than 30 international medtech, biotech and life-sciences startups to European investors, European business partners, research partners, and other key stakeholders.
Below is a highlighted list of RAPID-health alumni.
It is also possible to sort the company list by RAPID-Health edition:
AcadeMab Biomedical Inc.
Founded in 2020, AcadeMab Biomedical Inc. (hereinafter shortened as AM) is a start-up company dedicated to the development of new antibody drugs in the medical field that requires urgent breakthroughs. As cancer is widely acknowledged as a leading cause of death across the globe, we take it upon ourselves to research on the cancer therapy as our first step. From there, we expanded to other life-threaten diseases in different fields. To this end, we have developed multiple in-house technology platforms to break fresh ground for new antibody drugs. Our mission is to improve life quality and human health by providing the first-in-class or best-in-class new antibody drugs.
Sigknow Biomedical has ushered in a groundbreaking era of medical testing solutions by 2 major divisions —JustWipe® fecal occult blood test kit and EZYPRO® ECG recording system. Our core values are to satisfy the clinical need, to enhance the testing convenience, to optimize current modalities, and to foster a harmonious doctor-patient relationship.
The primary EZYPRO® team is committed to developing ECG hardware, an AI-empowered analysis system, a Bluetooth-enabled live view App, and a professional ECG analysis center. In terms of the accuracy of arrhythmia detections, it is clinically proven that EZYPRO® is >60% higher than 24hr Holter without compromising patients' comfort during wear. Our product serves well as a clinical diagnostic tool for medical professionals.
We are the first commercialized in-vitro tumor cell culture platform from liquid biopsy. Current cancer treatment is based on standard treatment protocols and physician experience, but individual differences make treatment methods work differently for each patient. Through our platform E.V.A. (Ex-Vivo Avatar), doctors will know the actual effect of drugs on patients’ cancer cells, and can further tailor treatment to patients’ conditions, reducing the risk of patients trying drugs on themselves and reducing the risk and cost of potential ineffective drugs.
E.V.A. is Circulating Tumor Cell – Derived Organoid (CDO) culture system containing 3D scaffolds to facilitate tumor cell proliferation. We have completed more than 800 real world data across more than 100 types of solid tumors. The early clinical data shows the average clinical response rate is 76.9%. E.V.A. can also help new cancer drug development companies to validate the drug suppression effect on tumor cells from real patients and screen for the clinical trial candidates. CancerFree Biotech is committed to developing a more competitive and personalized anti-cancer drug testing service.
Rongseng lab is founded by Prof. Rong Seng Chang in 1990. We started our research from optics design and then extended our interest in various fields. During past 30 years, we have developed our technology in optics, electronics, advanced material, thermal tech. and bio-tech. With our experienced research team, we can provide best technology solution for business clients.In 2018, one of our projects VIBRASEE won the APAC Global Impact Challenge from SU (Singularity University).
DFON BIOMEDICAL TECHNOLOGY
Our patented core technology is originally from cancer drug wrapping material. Using this technology, we have developed the skincare product with the best anti-aging effect. It keeps the highest amount of collagen in human skin, outstanding existing products on the market.
BROADSIMS Inc. is a new startup for medical electronics, focusing on cutting-edge medical technology and medical regulations. We expect to achieve excellence in technology and service integration in the Asia Pacific region by 2020 and establish an equivalent value service chain in Europe and the United States.
Our team come from medical regulatory verification, instrument and equipment development, and industrial automation, with more than 10 years of design experience in the hardware, and software of medical equipment.
As the global healthcare industry grows rapidly, we can provide highly integrated and value-added services that increase the value of the medical industry and accelerate the pace of global promotion.
Soteria Biotech Co., Ltd. is a Taiwan-based company that develops innovative medical software. It develops patents and sells products for respiratory diseases. Our first product “Soteria One Point Zero” is a medical cloud software designed to assist in the diagnosis and treatment of Obstructive Sleep Apnea Syndrome (OSAS). The development of this product originated from the CEO Honda Hsiao’s ten-year research in the sleep medicine field at the National Center for High-performance Computing. During the research period, he worked together with the Sleep Center of Chang Gung Memorial Hospital and the Sleep Center of China Medical University and successfully published results. Established Soteria Biotech Co., Ltd., and actively developed more advanced and better products. Currently, it has obtained patients in Taiwan, the United States and Singapore. The main target customers are patients with OSAS and patients waiting in line for diagnosis, to provide better solutions.
ARVIN Bio-Medical Devices Co., Ltd.
ARVIN Bio-Medical Devices Co., Ltd. is located next to Hsinchu Science Park, Taiwan. We are a team with high-tech and innovative ideas, and provide customers with complete and professional product solutions and services to create a win-win situation for both customers and the company. Our company's current main business and development are as follows:
1. Combined with medical technology, and developed a personal portable product.
2. Provide customized detection circuit module service.
3. Develop various detectors and combine mobile APP modules.
4. Develop 3D image scanner software/hardware.
5. Develop innovative medical materials in conjunction with clinicians and academia.
6. Medical equipment related consulting services.
Singular Wings Medical
Singular Wings Medical Co., Ltd. focus on health care and medical device including hardware design, software development and clouds platform services. Our products and services can be widely applied on resident care, disease care, health management, fitness, competitions, training, sports and other applications. We develop wearable devices which detect physiological signal and combine with smart watches, smart clothing, palm-type measurement device, etc.
Fall 2019, Spring 2023
MacroInsight Innovation Ltd.
MacroInsight is dedicated to developing and manufacturing revolutionary AI-based clinical decision support systems (CDSS) that are unmatched in the industry. MacroInsight’s AI-based CDSS can assist healthcare professionals by providing real-time analysis and interpretation of patient data, including medical images, lab results, and electronic health records (EHRs), enhancing healthcare professionals' decision-making capabilities and improving patient outcomes.
JelloX Biotech Inc
JelloX Biotech Inc. is a university startup by research team from National Tsing Hua University. JelloX owns exclusive in-license and invention patents to develop innovative digital imaging technology and AI analysis platform for next generation pathology with 3D digital pathology image and tissue feature-based diagnosis. We aim at creation of the world first 3D digital pathology solution in support of precision cancer diagnosis, optimize patient treatment outcome, and matching right patients with right drugs at right time. Our slogan is “Reimaging Pathology at New Horizan”
The company specializes in the research and development, manufacturing and sales of "medical imaging" equipment. Its main products include digital otoscopes, intraoral cameras, ophthalmoscopes, and head-mounted magnifiers. At present, the company's products are sold in more than ten countries around the world, and the application markets include: family medicine, pediatrics, otolaryngology, otology, veterinary medicine, ophthalmoscopes will be introduced to veterinarians first, and then human applications will be introduced next year.
MedicusTek is a global healthcare innovation company dedicated to improving patient safety and healthcare. MedicusTek helps to reduce bed falls and pressure injuries with a proprietary sensor technology and machine learning system. The predictive health A.I. actively monitors patients in bed and alerts caregivers in advance of potential bed exits and when patients need repositioning.
RedEye Biomedical (Taiwan RedEye Biomedical Inc.) was founded in Hsinchu in 2017 and entered Hsinchu science park in 2019. We focus on optical detection techniques and delve into some fields including Smart health, Food safety, and Environment protection.
The entry point of RedEye’s technology belongs to trace blood sensitivity, and more urine detection parameters related optical techniques, such as urine sugar, urine protein, uric acid, ketone bodies, and so on will be introduced in the future, and develop products that do not require any chemical use. With the members of research and development as the main operating point, cross-domain integration of optics, institutions, electronics, software, and biological, to create home use detection products.
iXensor is the pioneer of mobile health.
We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017.
The founding team of iXensor first met at Stanford University in 2011. At that time, they saw the rise of the smartphone and its potential to reshape future healthcare. In 2012, iXensor was founded in Silicon Valley and then incorporated in Taipei, Taiwan. Our interdisciplinary team combines expertise in medical engineering, biochemistry, and information technology to develop innovative digital health solutions that empower tomorrow's connected healthcare.
Our product lines cover Women’s Health, Chronic, and Infectious Diseases and are powered by our core technology - PixoTech® platform protected by more than 50 international patents. PixoTech® serves as the platform-as-a-service model and will be the engine for our next phase of growth.
We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.
We apply microfluidics as our core technique to develop an in vitro diagnostic (IVD) system to support the precision medicine of antibiotics. Targeting the emergence of antimicrobial resistance (AMR) which is literally one of the ten threats to the global health in 2019 according to WHO. Our system, fAST, can carry out rapid bacteria identification within 1.5 hours, following by a multiple antibiotics combination test within 5 hours. To conclude, we are the fastest and first-in-class system in the market that can optimize three different kind of antibiotics combination to provide clinicians with accurate and personalized results.
GEcoll Biomedical is the first gene editing application company in Taiwan with the frontier technology "Large-Segment gene editing, LS-Gene Editing”. Combining LS-Gene Editing with synthetic biology, GEcoll aims to produce safe and non-allergic biomaterials suitable for tissue repairing and regeneration. LS-Gene Editing can be applied on various biological platforms such as animals, plants and microorganisms to produce a variety of humanized biological materials for clinical, aesthetic as well as regenerative medicine.
Gene editing technology, likes Microsoft “Word”, which allows scientists to freely edit genes – inserting, deleting, revising and replacing DNA in plants, animals and even humans. It is a revolutionary invention. GEcoll’s LS-Gene Editing can simultaneously manipulate 3-10 times size of a target gene comparing with the existing gene editing technology. With LS-Gene Editing, GEcoll can speed-up R&D processes and precisely produce macromolecular proteins, overcoming the hurdle of mass production of large proteins. LS-Gene Editing can be applied to many fields such as clinical/basic medicine, agriculture and environmental protection.
LumiSTAR Biotechnology, Inc.
LumiSTAR Biotechnology is an expert in designs of a range of protein-based indicators for cellular dynamics measurements. Our expertise includes photochemistry, induced pluripotent stem cell (iPSC) technology, optogenetic tools and regenerative medicine. All of these technologies are packaged into an all-optical platform for phenotypic screening, drug discovery, and toxicity testing; the long-term goal is for precise/personal medicine. This high content platform enables customers to do their drug screening tasks in a more efficient and economical way. We offer a variety of functional assays for different disease modelling; customization service is also available.
The goal of LumiSTAR is to boost pharmaceutical industry and precise/personal medicine service by its niche of development of different luminescent/fluorescent proteins. This technology can also apply to bioluminescence/auto-luminescence products for green energy. We have a strong research team, and a close network in academia with world-leading research groups from Canada, UK, Singapore, Japan and Taiwan. We also collaborate with industries in device and medicine.
Super Genius AITEK
SG AITEK is a company familiar with the cross-domain integration of medical imaging and computer vision. Over the years, we have continued to provide customers with the most complete technical services and experience.
At present, the face recognition method is being developed to detect the vital signs with non-contact method, so as to promote everyone's health in the most convenient way. It is expected to continue to develop the advanced technologies and applications to serve the society, and take care of everyone's health and safety.
InwinStack is a professional service provider over ABCDE (AI, Blockchain, Cloud, Data Analytics and Edge Computing). Our customers get service to place their intellectual assets, process, works over cloud or decentralized on the edges. InwinStack serves government, campus, service providers, utility companies, eCommerce platform owner, manufacturer, research institutes and etc.. Our customers get consulting service, training service, initial setup, maintenance, disaster recovery service from InwinStack. InWinstack helps them to speedup the construction of infrastructure, own the capability to operate the system, continuous developing application, expand workloads over the system they build. Customer also enjoy continuous operation for performance enhancement, multi-system, multi-platform into automated tasks assignment.
The core technology and target product is the world's first focused ultrasound system-NaviFUS. The clinical use of this product is to apply ultrasound energy to the local cerebral blood vessels in a non-invasive way, causing the blood-brain barrier to be shielded. Temporarily relieved, the central nervous system drug can take advantage of this time to cross the blood-brain barrier and enter the brain lesion area, and then exert the expected therapeutic effect of the drug.
MATRIXLabs Medical Inc., founded by senior professionals from different disciplines containing clinical practices, medical devices, business development, industrial designs, and manufacturing, is committed to transform the present surgical suturing techniques in a safer and more efficient manner.
We are specialized in developing deep learning based medical image analysis and computer vision systems.
Research areas include
Automatic registration, detection, segmentation, recognition and reconstruction for multi-dimensional microscopic image, 3D/4D Cardiac MRI Image, Ultrasound Image, 3D confocal image, 3D CT scan, X ray image, live cell image, infrared image/video and gigapixel / terapixel ultra-high resolution medical image.
Applato is a platform to help people who have special health needs by providing real-time personalized dietary recommendation with algorithm developed by Applato team and meal order service with variety of tasty food choices from restaurants to solve meal prep problems to eat healthy, eat smart.
Targetrust Biotech. Ltd.
Based on the world’s first invention of the “Tumor Signal – Liquid Biopsy” method (assaying tumor signal transduction activity in blood), Targetrust Biotech. Ltd. is commercializing the DxSure reagent for early, real-time, sensitive, and cost-saving monitoring of the therapy resistance of all cancer types and all therapy methods such as targeted therapy, chemotherapy, immunotherapy, and radiation therapy.
Advanced Biomedical Technology Inc. (ABT)
Advanced biomedical technology (ABT) is a startup who focusing on 3D printing biodegradable implant. ABT was founded in Taiwan and have GMP facility for medical grade 3D printing service. ABT provide the service with high quality and high-performance medical grade biomaterials, biodegradable implant and 3D printing total solution.
Bio Preventive Medicine Corp. (BPM)
Bio Preventive Medicine (BPM) is an innovative clinical-staged biotech company, focusing on early detection and prevention of diseases specialty of those high value added molecular diagnostic product. BPM was invested mainly by angels and Top Taiwan Venture Capital. As an ITRI spin-off startup, BPM was founded in Q3 2014 with headquarter in Hsinchu, Taiwan.
With its core technologies derived from a National Biomarker Project, which has been sponsored by MOEA for years, BPM launched its first product “DNlite” in 2014. DNlite Test, a non-invasive urinary test for monitoring the progression of Diabetic Nephropathy, will be an effective tool for managing renal complications in diabetes and help patients from the nightmare of dialysis. In addition to technology for diabetic nephropathy, the proprietary technologies of BPM also include biomarker-based diagnostic technology for other chronic diseases and oncology.
Ascendo Biotechnology, Inc
Ascendo Biotechnology is a fast-growing biotechnology company based in Taiwan that is pioneering novel approaches to developing cancer immunotherapies and functional cures for chronic viral infections.
Our therapeutic strategies focus on the interplay between the natural innate and adaptive immune pathways to reinvigorate the immunity of the tumor microenvironment for a comprehensive anti-tumor response.
Our lead oncology product, ASD141, is an innate immune checkpoint inhibitor (ICI) that commands a controlled, active innate immune response to solid tumors. It does this by blocking TLT-1, a key regulatory protein that induces the immune suppressive environment in the tumor.
In addition to ICIs, we are building a diverse pipeline which includes NanoCherub®, our nanocomplex platform technology of which several our early-stage injectable, oral therapeutic and prophylactic vaccines are based.
The 24-hour Ambulatory Blood Pressure Monitoring has some problems in use, causing the user to be unwilling to try, and also making it impossible for the doctor to judge whether he/she has high blood pressure or proper treatment and administration. Accurate 24 is the world’s first sphygmomanometer that can be used in the night without disturbing the patient and can measure continuously for 24 hours, and can synchronize the vital signs with the remote doctor at any time.
EPED Inc. is a value-added medical and dental navigation solutions provider which provides surgeons with high quality, cutting-edge navigation technologies.
EPED Inc. is a leading company in the field of minimally invasive surgery. Upholding the values of “safety, precision, efficiency and minimally invasive”, we strive constantly to develop innovative medical and dental navigation solutions complemented with AR Technology. From education, training systems to clinical solutions, we are dedicated to enhancing the quality and safety of medical treatment on all levels.
Neurobit was founded in 2016 by Travis Yang, Jim Huang, Ching-Fu Wang and Roger Chen while they were students at National Taiwan University. With the aim of providing revolutionary technology to the medical community, we have been developing our own hardware and software solution, offering comprehensive neuro-functional digital diagnostic system that ease the lives of healthcare professionals around the globe.
Our mission is to solve unmet neuro-clinical needs and offer a triple-win solution to professionals, patients and insurance companies.
Biotegy is an innovative platform focusing on design, development and pilot manufacturing for medical technologies. Biotegy has special expertise on design and development of biomaterials, medical implants, cell therapy procedures, and innovative medical devices. By partnership with medical doctors and scientists, the clinical unmet needs are discovered and transformed to potential medical products. Biotegy is devoted to maximizing the values of the developed medical products based on the innovation, incubation, and integration processes.
In 2018, Brain Navi Biotechnology developed NaoTrac, the first Autonomous surgical navigation robot with machine vision specially designed for cranial neurosurgery. Until current research, it is enough to fit in the routine clinical setting. Brain Navi Biotechnology is mainly focusing on developing and researching innovative neurosurgical navigation system.
With the outstanding doctors, researchers, and developers in Taiwan to combine technical and clinical application experience, developing products driven by demand. Takes Taiwan’s advantages in R&D and production in the electronics industry, selecting Taiwan as a research and development and production base. Brain Navi will focus on the global market and create sustainable value management.
imedtac is an AIoT healthcare expert, established in Taiwan. With our in-depth knowledge of hospital needs and years of experience in IoMT, we’re determined to improve the operational efficiency of the healthcare industry to help ease caregivers’ workloads, prevent medical errors, and enhance patient satisfaction.
Instant NanoBiosensors Co., Ltd. is an award-winning Taiwanese start-up, specialized in the development of cutting-edge biosensor platforms. Established in 2016 by co-founder Tsun-Chih ''Tony'' Chung (CEO), Lai-Kwan Chau (PhD), and Shau-Chun ''Paul'' Wang (PhD), this aspiring biotechnology company operates on the mission to continuously improve biomedical research and diagnostic processes with simple, reliable and affordable detection solutions.
With the unique & patented FOPPR™ Technology (Fiber Optic Particle Plasmon Resonance), the Light-Sensing Biomarker Analyzer platforms offer instant and accurate results for a variety of applications. By combining novel biomarker with advantageous devices and biochips, we have the vision to revolutionize traditional immunoassays and diagnostic analyses for a more efficient healthcare ecosystem:
To share our extensive experience and industry knowledge, we are offering since 2020 via our business unit INvision products focused on Genomics and Molecular Biology, respectively high-class Automated Nucleic Acid Purification Platforms and PCR/qPCR One-Step Reagents.
Energy Resources International Co. Ltd.
Energy Resources International Co., Ltd. (ERI), a pioneer in X-ray radiography, has stepped into medical equipment field and has dedicated to its effort to explore and master the properties and application of Carbon Nanotube (CNT) technology since 2013. The first area of focus has been in the development of world’s first CNT-driven Cold Cathode as the X-ray emission source. ERI has applied this technological breakthrough first to the development of the battery-powered handheld X-ray devices. These handheld devices not only drastically change the experience of the dental patients but also lower the operating costs of the dentist offices. From the handheld devices, ERI proceeds to explore opportunities in the portable general purpose X-ray systems for extremities with the vision to continuously improve the timeliness, convenience, and effectiveness of the X-ray experiences. In addition to using and improving X-ray as a diagnostic tool, ERI has been exploring opportunities on the treatment side of the healthcare needs. The most recent conversation on the treatment side surrounds the ground-breaking Intraoperative Radiotherapy (IORT) for breast and skin cancer therapy.
AnHorn Medicines Co., Ltd.
AnHorn Medicines is a novel drug discovery company with a strong pipeline, offering therapies that target and degrade disease-related proteins. Our mission is to develop new class of drugs BIGPRO® (Bi-functional liGand induced PROteolysis) under the foundation of Targeted Protein Degradation (TPD), to address a broad range of life-threatening and life-impairing diseases.
We focus on novel therapies for cancer, neurodegeneration, and aging diseases. We are turning innovation into new therapeutics – new opportunities to target difficult-to-treat diseases and diseases plagued by drug resistance.
Our proprietary BIGPRO® protein degrader gives precise elimination of diseased protein that helps the human body to return to a healthy state.